News

The Japanese Ministry of Health, Labor and Welfare has approved Cimzia as a 200mg syringe for subcutaneous (s.c.) injection to treat adult RA patients who failed to respond

In August 2011, the companies decided to suspend the pramlintide/metreleptin investigational combination therapy development. The decision was based on a commercial re-assessment of the program, which had been

The company is seeking approval for the label expansion of Feraheme to include all iron deficiency anemia (IDA) patients who cannot take oral iron. At present, Ferumoxytol is

Ryzodeg, which has been approved to be administered once or twice daily, is the global brand name for insulin degludec/insulin aspart and contains Tresiba and NovoRapid. Tresiba is

Juxtapid, which is a supplement to fat reduction treatments also includes availability of LDL apheresis, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B)

Tamiflu works by blocking the ability of the virus to replicate in the body thereby inhibiting the duration and severity of influenza. With the approval, Tamiflu becomes the

The trial will evaluate the safety and pharmacokinetic profile of single and multi-dose administration of IW-2143, which was discovered by Bionomics, in healthy volunteers. Bionomics CEO and managing

The data analysis failed to detect an effect of davunetide on either the Progressive Supranuclear Palsy Rating Scale and the Schwab and England Activities of Daily Living. The

The study aims to compare the safety and efficacy of ocular iontophoresis with dexamethasone phosphate ophthalmic solution (EGP-437) in relation to topically applied prednisolone acetate (1%) ophthalmic suspension